Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy

Contraception ◽  
2011 ◽  
Vol 84 (2) ◽  
pp. 133-143 ◽  
Author(s):  
Inka Wiegratz ◽  
Skadi Stahlberg ◽  
Torsten Manthey ◽  
Nicole Sänger ◽  
Katrin Mittmann ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Contraceptive Efficacy ◽  
Extended Cycle

scholarly journals Safety and Efficacy of Levonorgestrel 0.10 mg and Ethinyl Estradiol 0.02 mg plus Ethinyl Estradiol 0.01 mg in an Extended-Cycle Oral Contraceptive Regimen

2010 ◽  
Vol 2 ◽  
pp. CMT.S4661
Author(s):  
Radhika Rible ◽  
Ram Parvataneni ◽  
Angela Chen
Keyword(s):  
Oral Contraceptive ◽  
Ethinyl Estradiol ◽  
Hormonal Contraception ◽  
Pivotal Trial ◽  
Combined Oral Contraceptive ◽  
Free Interval ◽  
Effective Option ◽  
Effective Contraception ◽  
Combined Hormonal Contraception ◽  
Extended Cycle

Extended-cycle combined hormonal contraception has become a common practice among women seeking effective contraception and menstrual regulation. Extended cycle regimens have the benefit of decreasing scheduled bleeding as compared to traditional combined oral contraceptive (COC) regimens containing 21 days of hormones followed by a 7-day hormone-free interval (HFI) by reducing the frequency of the HFI. The newest FDA approved product in this family of contraceptive regimens is a 91-day COC regimen containing 0.02 mg ethinyl estradiol (EE) and 0.1 mg levonorgestrel (LNG) for 84 days followed by a 7-day interval with 0.01 mg EE. This regimen has been evaluated in one pivotal trial and demonstrated to have efficacy and a side effect profile similar to the other currently available FDA approved 91-day extended-cycle regimens. This is the first 91-day regimen formulated with 0.02 mg EE and offers women an effective option for contraception and menstrual cycle control.

scholarly journals Extended-Cycle Oral Contraceptive Pills with 10 μG Ethinyl Estradiol Pills in Place of Placebo Pills

2007 ◽  
Vol 3 (5) ◽  
pp. 529-535 ◽  
Author(s):  
Anita L Nelson
Keyword(s):  
Oral Contraceptive ◽  
Birth Control ◽  
Low Dose ◽  
Ethinyl Estradiol ◽  
Oral Contraceptive Pills ◽  
Contraceptive Pills ◽  
Unscheduled Bleeding ◽  
Birth Control Pills ◽  
Extended Cycle ◽  
Stimulation Of

The elimination of monthly withdrawal bleeding with use of extended-cycle (84 pills) monophasic birth-control pills has modernized oral contraceptives. The use of ethinyl estradiol 10 μg pills in place of the seven placebo pills addresses the problems posed by 21/7 formulations of low-dose birth-control pills, which allow early stimulation of ovarian follicles, and of the early 84/7 formulations, which had higher rates of unscheduled bleeding and spotting.

Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen

Contraception ◽  
2005 ◽  
Vol 71 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Freedolph D. Anderson ◽  
Howard Hait ◽  
Jeng Hsiu ◽  
Allison L. Thompson-Graves ◽  
Walter H. Wilborn ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Extended Cycle
Sign in / Sign up

Export Citation Format

Share Document